Acute obstetric coagulopathy during postpartum hemorrhage is caused by hyperfibrinolysis and dysfibrinogenemia: an observational cohort study

de Lloyd, Lucy, Jenkins, Peter V., Bell, Sarah F., Mutch, Nicola J., Martins Pereira, Julia Freyer, Badenes, Pilar M., James, Donna, Ridgeway, Anouk, Cohen, Leon, Roberts, Thomas, Field, Victoria, Collis, Rachel E. and Collins, Peter W. ORCID: https://orcid.org/0000-0002-6410-1324 2023. Acute obstetric coagulopathy during postpartum hemorrhage is caused by hyperfibrinolysis and dysfibrinogenemia: an observational cohort study. Journal of Thrombosis and Haemostasis 21 (4) , pp. 862-879. 10.1016/j.jtha.2022.11.036

Preview	PDF - Accepted Post-Print Version Download (607kB) | Preview
Preview	Image (TIFF) (Figure 1) - Supplemental Material Download (347kB) | Preview
Preview	Image (TIFF) (Figure 2) - Supplemental Material Download (238kB) | Preview

Abstract

Background Postpartum hemorrhage (PPH) may be exacerbated by hemostatic impairment. Information about PPH-associated coagulopathy is limited, often resulting in treatment strategies based on data derived from trauma studies. Objectives To investigate hemostatic changes associated with PPH. Patients/Methods From a population of 11 279 maternities, 518 (4.6%) women were recruited with PPH ≥ 1000 mL or placental abruption, amniotic fluid embolism, or concealed bleeding. Routine coagulation and viscoelastometric results were collated. Stored plasma samples were used to investigate women with bleeds > 2000 mL or those at increased risk of coagulopathy defined as placenta abruption, amniotic fluid embolism, or need for blood components. Procoagulant factors were assayed and global hemostasis was assessed using thrombin generation. Fibrinolysis was investigated with D-dimer and plasmin/antiplasmin complexes. Dysfibrinogenemia was assessed using the Clauss/antigen ratio. Results At 1000 mL blood loss, Clauss fibrinogen was ≤2 g/L in 2.4% of women and 6/27 (22.2%) cases of abruption. Women with very large bleeds (>3000 mL) had evidence of a dilutional coagulopathy, although hemostatic impairment was uncommon. A subgroup of 12 women (1.06/1000 maternities) had a distinct coagulopathy characterized by massive fibrinolysis (plasmin/antiplasmin > 40 000 ng/mL), increased D-dimer, hypofibrinogenemia, dysfibrinogenemia, reduced factor V and factor VIII, and increased activated protein C, termed acute obstetric coagulopathy. It was associated with fetal or neonatal death in 50% of cases and increased maternal morbidity. Conclusions Clinically significant hemostatic impairment is uncommon during PPH, but a subgroup of women have a distinct and severe coagulopathy characterized by hyperfibrinolysis, low fibrinogen, and dysfibrinogenemia associated with poor fetal outcomes.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Wiley
ISSN:	1538-7836
Date of First Compliant Deposit:	20 February 2023
Date of Acceptance:	13 November 2022
Last Modified:	11 Nov 2024 08:45
URI:	https://orca.cardiff.ac.uk/id/eprint/157161

Actions (repository staff only)

Edit Item